Search results
The pages "Expert Review of Neurotherapeutics" and '"Expert Review of Neurotherapeutics"' do not exist. You can create a draft and submit it for review or request that a redirect be created, but consider checking the search results below to see whether the topic is already covered.
- epilepsy: from basic rationale to practical application". Expert Review of Neurotherapeutics. 6 (2): 247–257. doi:10.1586/14737175.6.2.247. PMID 16466304...7 KB (820 words) - 17:05, 21 February 2024
- Activities of Daily Living Scale: a critical evaluation". Expert Review of Neurotherapeutics. 2 (5): 669–676. doi:10.1586/14737175.2.5.669. PMID 19810983...3 KB (158 words) - 15:54, 22 October 2022
- diseases following alemtuzumab therapy for multiple sclerosis". Expert Review of Neurotherapeutics. 12 (3): 335–41. doi:10.1586/ern.12.5. PMID 22364332. S2CID 34738692...8 KB (722 words) - 15:17, 22 March 2023
lessons from congenital insensitivity to pain with anhidrosis". Expert Review of Neurotherapeutics. 10 (11): 1707–1724. doi:10.1586/ern.10.154. hdl:2298/23889...8 KB (736 words) - 14:33, 31 August 2024- 2010). "Management of antipsychotic-related weight gain". Expert Review of Neurotherapeutics. 10 (7): 1175–200. doi:10.1586/ern.10.85. PMC 3501406. PMID 20586697...9 KB (854 words) - 16:27, 1 February 2024
modification for anxiety: Current evidence and future directions". Expert Review of Neurotherapeutics. 11 (2): 299–311. doi:10.1586/ern.10.194. PMC 3092585. PMID 21306216...19 KB (2,378 words) - 04:33, 19 February 2024- craniotomy for brain tumor: indications, technique and benefits". Expert Review of Neurotherapeutics. 14 (12): 1405–1415. doi:10.1586/14737175.2014.979793. ISSN 1744-8360...8 KB (873 words) - 21:02, 8 August 2024
- management of spasticity associated with multiple sclerosis". Expert Review of Neurotherapeutics. 11 (5): 627–637. doi:10.1586/ern.11.47. ISSN 1473-7175. PMID 21456949...16 KB (1,680 words) - 16:53, 6 September 2024
understanding and treating children with selective mutism". Expert Review of Neurotherapeutics. 9 (2): 235–243. doi:10.1586/14737175.9.2.235. ISSN 1744-8360...18 KB (1,853 words) - 12:24, 10 September 2024
environmental dimension of MS, Lauer compiled a review in Expert Review of Neurotherapeutics. Since 1992, Lauer has published a large number of epidemiological...19 KB (2,015 words) - 08:53, 18 August 2023- optica spectrum: a review of emerging treatment options". Expert Review of Neurotherapeutics. 20 (5). Informa UK Limited: 509–516. doi:10.1080/14737175...18 KB (1,449 words) - 13:26, 7 September 2024
acute treatment of migraine: similarities and differences". Expert Review of Neurotherapeutics. 13 (9): 961–963. doi:10.1586/14737175.2013.832851. PMID 23980649...17 KB (1,866 words) - 03:11, 3 September 2024
with cyclin-dependent kinase-like 5 deficiency disorder". Expert Review of Neurotherapeutics: 1–7. doi:10.1080/14737175.2024.2385937. PMID 39082513. Khan...13 KB (924 words) - 05:42, 12 September 2024
for the treatment of mild to moderate Alzheimer's disease". Expert Review of Neurotherapeutics. 15 (6): 587–596. doi:10.1586/14737175.2015.1045419. PMID 25961655...11 KB (847 words) - 12:36, 5 August 2024- (February 2007). "Emerging treatments for major depression". Expert Review of Neurotherapeutics. 7 (2): 203–13. doi:10.1586/14737175.7.2.203. PMID 17286553...5 KB (476 words) - 13:33, 18 January 2024
diseases following alemtuzumab therapy for multiple sclerosis". Expert Review of Neurotherapeutics. 12 (3): 335–341. doi:10.1586/ern.12.5. PMID 22364332. S2CID 34738692...19 KB (1,903 words) - 02:49, 24 August 2024
and Frontiers in Neurology. He is the editor-in-chief for Expert Review of Neurotherapeutics. He has served on the executive scientific advisory boards...6 KB (614 words) - 16:30, 5 August 2023
(April 2008). "Dopamine agonists in Parkinson's disease". Expert Review of Neurotherapeutics. 8 (4): 671–7. doi:10.1586/14737175.8.4.671. PMID 18416667...16 KB (1,532 words) - 22:51, 18 August 2023
classification and differential diagnosis of orofacial pain". Expert Review of Neurotherapeutics. 12 (5): 569–76. doi:10.1586/ern.12.40. PMID 22550985. S2CID 32890328...14 KB (1,510 words) - 21:01, 6 August 2024
neuropsychiatric diseases: Review and treatment recommendations" (PDF). Expert Review of Neurotherapeutics. 9 (9): 1393–412. doi:10.1586/ern.09.75. PMID 19769453. S2CID 13246020...20 KB (2,109 words) - 18:23, 9 September 2024
- Sanchez-Ramos, A. Bozorg et al., “Medical marijuana in neurology,” Expert Review of Neurotherapeutics, vol. 14, no. 12, pp. 1453–1465, 2014. J. M. Cunha, E. A.
- pharmacotherapy of attention-deficit/hyperactivity disorder in adults. Expert Review of Neurotherapeutics, 11(10), 1443-1465 Arnsten, A. (2006). Stimulants: Therapeutic